There are 2789 resources available
Avenues for accessing drugs in small patient population settings: Access to clinical trials, off-label and compassionate use in Europe
Presenter: Christophe Massard
Session: Successful strategies for tumour agnostic treatment approaches
Resources:
Slides
Webcast
Portfolio of tests for tumour-agnostic markers: Disease-specific or broad panels?
Presenter: Caterina Marchiò
Session: Successful strategies for tumour agnostic treatment approaches
Resources:
Slides
Webcast
Introduction, definition of oligometastatic disease and presentation of case/condition
Presenter: Christophe Tournigand
Session: Oligometastatic colorectal cancer: Don’t miss the boat
Resources:
Slides
Webcast
Interventional radiology: Approaches that may help
Presenter: Thierry de Baere
Session: Oligometastatic colorectal cancer: Don’t miss the boat
Resources:
Slides
Webcast
Surgical indications and limitations
Presenter: Graeme Poston
Session: Oligometastatic colorectal cancer: Don’t miss the boat
Resources:
Slides
Webcast
Radiotherapy for metastatic colorectal cancer (mCRC): When is it worth it?
Presenter: Karin Haustermans
Session: Oligometastatic colorectal cancer: Don’t miss the boat
Resources:
Slides
Webcast
Introduction
Presenter: Anna Obenauf
Session: Biology-guided combination cancer therapy
Resources:
Webcast
The value of genomics information for trial design
Presenter: Edwin Cuppen
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast
Combining radiotherapy and DNA repair inhibition
Presenter: Anthony Chalmers
Session: Biology-guided combination cancer therapy
Resources:
Slides
Combining immunotherapy and kinase inhibition
Presenter: Anna Obenauf
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast